![Thorsten von Stein](https://cdn.zonebourse.com/static/resize/768/576//static/images/insiders/unknown.png)
Thorsten von Stein
Keine laufenden Positionen mehr
Karriereverlauf von Thorsten von Stein
Ehemalige bekannte Positionen von Thorsten von Stein
Unternehmen | Position | Beginn | Ende |
---|---|---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.2005 | 03.02.2014 |
NEUROGESX, INC | Technik-/Wissenschafts-/F&E-Leiter | 01.12.2001 | 01.01.2005 |
Roche Palo Alto LLC
![]() Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Technik-/Wissenschafts-/F&E-Leiter | 01.01.1998 | 01.12.2001 |
ZP Opco, Inc.
![]() ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Technik-/Wissenschafts-/F&E-Leiter | - | - |
ZOSANO PHARMA CORPORATION | Technik-/Wissenschafts-/F&E-Leiter | 28.04.2015 | - |
Ausbildung von Thorsten von Stein
Ludwig-Maximilians-Universität München | Doctorate Degree |
University of Hamburg | Doctorate Degree |
Statistik
International
Vereinigte Staaten | 6 |
Deutschland | 3 |
Operativ
Chief Tech/Sci/R&D Officer | 5 |
Doctorate Degree | 2 |
Sektoral
Health Technology | 6 |
Consumer Services | 3 |
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Unternehmensverbindungen
Private Unternehmen | 5 |
---|---|
Tercica, Inc.
![]() Tercica, Inc. Pharmaceuticals: MajorHealth Technology The Company's principal activity as a biopharmaceutical company is focused on the development and commercialization of products to improve endocrine health. Its first product, IncrelexTM (mecasermin {rDNA origin} injection), or recombinant human insulin-like growth factor-1 (rhIGF-1), is approved by the FDA for the treatment of severe Primary IGFD. The Company licensed the rights to develop, manufacture and commercialize Increlex from Genentech Inc. | Health Technology |
NeurogesX, Inc.
![]() NeurogesX, Inc. Pharmaceuticals: MajorHealth Technology NeurogesX, Inc. developed and commercialized novel pain management therapies. The company was founded by Wendye R. Robbins on May 28, 1998 and was headquartered in San Mateo, CA. | Health Technology |
Roche Palo Alto LLC
![]() Roche Palo Alto LLC Pharmaceuticals: MajorHealth Technology Roche Palo Alto LLC discovers and develops medicines. Its medicines are used for the treatment of central nervous system, inflammation, metabolism, oncology, and virology diseases. The company was founded in 1961 and is headquartered in Palo Alto, CA. | Health Technology |
Zosano Pharma Corp.
![]() Zosano Pharma Corp. Pharmaceuticals: MajorHealth Technology Zosano Pharma Corp. is a clinical stage biopharmaceutical company, which engages in the development of human pharmaceutical products. It also focuses on providing rapid systemic administration of therapeutics to patients using proprietary intracutaneous microneedle system. The company was founded in October 2006 and is headquartered in Fremont, CA. | Health Technology |
ZP Opco, Inc.
![]() ZP Opco, Inc. Pharmaceuticals: MajorHealth Technology ZP Opco, Inc. operates as a biopharmaceutical company that develops transdermal delivery technology for therapeutic indications. The company was founded by Peter E. Daddona and Frank D. Stonebanks in 2006 and is headquartered in Fremont, CA. | Health Technology |
- Börse
- Insiders
- Thorsten von Stein
- Erfahrung